117 related articles for article (PubMed ID: 18304682)
1. Iron and the liver: update 2008.
Deugnier Y; Brissot P; Loréal O
J Hepatol; 2008; 48 Suppl 1():S113-23. PubMed ID: 18304682
[TBL] [Abstract][Full Text] [Related]
2. Increased serum hepcidin levels during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndrome.
Ghoti H; Fibach E; Westerman M; Gordana O; Ganz T; Rachmilewitz EA
Br J Haematol; 2011 Apr; 153(1):118-20. PubMed ID: 21332711
[TBL] [Abstract][Full Text] [Related]
3. Deferasirox reduces iron overload in a murine model of juvenile hemochromatosis.
Nick H; Allegrini PR; Fozard L; Junker U; Rojkjaer L; Salie R; Niederkofler V; O'Reilly T
Exp Biol Med (Maywood); 2009 May; 234(5):492-503. PubMed ID: 19234060
[TBL] [Abstract][Full Text] [Related]
4. Oral iron chelator deferasirox in the treatment of secondary hemochromatosis following bone marrow transplantation in a patient with severe aplastic anemia.
Quarta A; Melpignano A; Quarta G
Acta Haematol; 2011; 125(4):219-21. PubMed ID: 21266801
[TBL] [Abstract][Full Text] [Related]
5. Review article: the iron overload syndromes.
Siddique A; Kowdley KV
Aliment Pharmacol Ther; 2012 Apr; 35(8):876-93. PubMed ID: 22385471
[TBL] [Abstract][Full Text] [Related]
6. [Hepcidin--the discovery of a small protein with a pivotal role in iron homeostasis].
Sela BA
Harefuah; 2008 Mar; 147(3):261-6, 276. PubMed ID: 18488871
[TBL] [Abstract][Full Text] [Related]
7. Current approach to hemochromatosis.
Brissot P; Troadec MB; Bardou-Jacquet E; Le Lan C; Jouanolle AM; Deugnier Y; Loréal O
Blood Rev; 2008 Jul; 22(4):195-210. PubMed ID: 18430498
[TBL] [Abstract][Full Text] [Related]
8. [Haemochromatoses. New understanding, new treatments].
Brissot P
Gastroenterol Clin Biol; 2009; 33(8-9):859-67. PubMed ID: 19577392
[TBL] [Abstract][Full Text] [Related]
9. The liver in haemochromatosis.
Ulvik RJ
J Trace Elem Med Biol; 2015; 31():219-24. PubMed ID: 25204225
[TBL] [Abstract][Full Text] [Related]
10. New insights into the regulation of iron homeostasis.
Deicher R; Hörl WH
Eur J Clin Invest; 2006 May; 36(5):301-9. PubMed ID: 16634833
[TBL] [Abstract][Full Text] [Related]
11. Deferasirox (Exjade) for the treatment of iron overload.
Cappellini MD; Taher A
Acta Haematol; 2009; 122(2-3):165-73. PubMed ID: 19907154
[TBL] [Abstract][Full Text] [Related]
12. Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation.
Finkenstedt A; Wolf E; Höfner E; Gasser BI; Bösch S; Bakry R; Creus M; Kremser C; Schocke M; Theurl M; Moser P; Schranz M; Bonn G; Poewe W; Vogel W; Janecke AR; Zoller H
J Hepatol; 2010 Dec; 53(6):1101-7. PubMed ID: 20801540
[TBL] [Abstract][Full Text] [Related]
13. Conditional disruption of mouse HFE2 gene: maintenance of systemic iron homeostasis requires hepatic but not skeletal muscle hemojuvelin.
Gkouvatsos K; Wagner J; Papanikolaou G; Sebastiani G; Pantopoulos K
Hepatology; 2011 Nov; 54(5):1800-7. PubMed ID: 21748766
[TBL] [Abstract][Full Text] [Related]
14. [Genetic iron overload diseases: a deeply changing world].
Brissot P; Troadec MB; Le Lan C; Lorho R; Gaboriau F; Lescoat G; Jouanolle AM; Loréal O
Nephrol Ther; 2006 Nov; 2 Suppl 5():S298-303. PubMed ID: 17373274
[TBL] [Abstract][Full Text] [Related]
15. Hepcidin treatment in Hfe-/- mice diminishes plasma iron without affecting erythropoiesis.
Morán-Jiménez MJ; Méndez M; Santiago B; Rodríguez-García ME; Moreno-Carralero MI; Sánchez-Lucío AC; Grau M; Enríquez-de-Salamanca R
Eur J Clin Invest; 2010 Jun; 40(6):511-7. PubMed ID: 20456487
[TBL] [Abstract][Full Text] [Related]
16. Iron absorption and metabolism.
Anderson GJ; Frazer DM; McLaren GD
Curr Opin Gastroenterol; 2009 Mar; 25(2):129-35. PubMed ID: 19528880
[TBL] [Abstract][Full Text] [Related]
17. Iron metabolism and related genetic diseases: A cleared land, keeping mysteries.
Brissot P; Loréal O
J Hepatol; 2016 Feb; 64(2):505-515. PubMed ID: 26596411
[TBL] [Abstract][Full Text] [Related]
18. Deferasirox administration for the treatment of non-transfusional iron overload in patients with thalassaemia intermedia.
Ladis V; Berdousi H; Gotsis E; Kattamis A
Br J Haematol; 2010 Dec; 151(5):504-8. PubMed ID: 20950401
[TBL] [Abstract][Full Text] [Related]
19. Disorders of iron metabolism. Part II: iron deficiency and iron overload.
Muñoz M; García-Erce JA; Remacha ÁF
J Clin Pathol; 2011 Apr; 64(4):287-96. PubMed ID: 21177268
[TBL] [Abstract][Full Text] [Related]
20. Iron mobilization using chelation and phlebotomy.
Flaten TP; Aaseth J; Andersen O; Kontoghiorghes GJ
J Trace Elem Med Biol; 2012 Jun; 26(2-3):127-30. PubMed ID: 22565013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
